David L. Wensel

发表

A Virus-Virus Interaction Circumvents the Virus Receptor Requirement for Infection by Pathogenic Retroviruses

J. Cunningham, David L. Wensel, Weihua Li, 2003, Journal of Virology.

Discovery and Characterization of a Novel CD4-Binding Adnectin with Potent Anti-HIV Activity

D. Fabrizio, M. Krystal, M. Cockett, 2017, Antimicrobial Agents and Chemotherapy.

Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeys

Y. Vugmeyster, A. Wahl, K. Mohler, 2011, Rheumatology.

Complex Pharmacokinetics of a Humanized Antibody Against Human Amyloid Beta Peptide, Anti-Abeta Ab2, in Nonclinical Species

Y. Vugmeyster, Xin Xu, D. Gill, 2011, Pharmaceutical Research.

Structure and Mechanism of a Coreceptor for Infection by a Pathogenic Feline Retrovirus

J. Cunningham, D. Fass, A. Barnett, 2003, Journal of Virology.

High-throughput screening of chromatographic separations: III. Monoclonal antibodies on ceramic hydroxyapatite.

B. Kelley, David L Wensel, Brian D Kelley, 2008, Biotechnology and bioengineering.

Developing Adnectins that target SRC co-activator binding to PXR: a structural approach toward understanding promiscuity of PXR.

Eric T Baldwin, Martin C. Wright, Andrew J Tebben, 2015, Journal of molecular biology.

Novel Bent Conformation of CD4 Induced by HIV-1 Inhibitor Indirectly Prevents Productive Viral Attachment.

C. Mazzucco, M. Krystal, D. Dixon, 2021, Journal of molecular biology.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

GSK3732394: a Multi-specific Inhibitor of HIV Entry

D. Langley, P. Nef, M. Krystal, 2019, Journal of Virology.

A Novel gp41-Binding Adnectin with Potent Anti-HIV Activity Is Highly Synergistic when Linked to a CD4-Binding Adnectin

D. Fabrizio, M. Krystal, M. Cockett, 2018, Journal of Virology.

The N17 region of gp41 in HIV-1 is the most conserved region in gp160. mRNA selection

D. Fabrizio, M. Krystal, M. Cockett, 2018 .

A Functional NaV1.7-NaVAb Chimera with a Reconstituted High-Affinity ProTx-II Binding Site

D. Langley, J. Herrington, M. Ahlijanian, 2017, Molecular Pharmacology.

A Phase 1 randomized study of GSK3732394, an investigational long-acting biologic treatment regimen for HIV-1 infection

M. Krystal, Allen Wolstenholme, Shiven B Chabria, 2022, Antiviral Therapy.

A Functional NaV1.7-NaVAb Chimera with a Reconstituted High-Affinity ProTx-II Binding Site

D. Langley, J. Herrington, M. Ahlijanian, 2017, Molecular Pharmacology.